<VariationArchive VariationID="163343" VariationName="NM_005228.5(EGFR):c.2235_2249del (p.Glu746_Ala750del)" VariationType="Deletion" Accession="VCV000163343" Version="13" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2015-01-31" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="174234" VariationID="163343">
      <GeneList>
        <Gene Symbol="EGFR" FullName="epidermal growth factor receptor" GeneID="1956" HGNC_ID="HGNC:3236" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="55019017" stop="55211628" display_start="55019017" display_stop="55211628" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="55086724" stop="55275030" display_start="55086724" display_stop="55275030" Strand="+" />
          </Location>
          <OMIM>131550</OMIM>
          <Haploinsufficiency last_evaluated="2022-05-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EGFR">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-05-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EGFR">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005228.5(EGFR):c.2235_2249del (p.Glu746_Ala750del)</Name>
      <CanonicalSPDI>NC_000007.14:55174771:GGAATTAAGAGAAGC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="55174772" stop="55174786" display_start="55174772" display_stop="55174786" variantLength="15" positionVCF="55174771" referenceAlleleVCF="AGGAATTAAGAGAAGC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="55242465" stop="55242479" display_start="55242465" display_stop="55242479" variantLength="15" positionVCF="55242464" referenceAlleleVCF="AGGAATTAAGAGAAGC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.55242465_55242479del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.55242465_55242479del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.55174772_55174786del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.55174772_55174786del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007726.3" sequenceAccession="NG_007726" sequenceVersion="3" change="g.160741_160755del">
            <Expression>NG_007726.3:g.160741_160755del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346897.2" sequenceAccession="NM_001346897" sequenceVersion="2" change="c.2100_2114del">
            <Expression>NM_001346897.2:c.2100_2114del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333826.1" sequenceAccession="NP_001333826" sequenceVersion="1" change="p.Glu701_Ala705del">
            <Expression>NP_001333826.1:p.Glu701_Ala705del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346898.2" sequenceAccession="NM_001346898" sequenceVersion="2" change="c.2235_2249del">
            <Expression>NM_001346898.2:c.2235_2249del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333827.1" sequenceAccession="NP_001333827" sequenceVersion="1" change="p.Glu746_Ala750del">
            <Expression>NP_001333827.1:p.Glu746_Ala750del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346899.2" sequenceAccession="NM_001346899" sequenceVersion="2" change="c.2100_2114del">
            <Expression>NM_001346899.2:c.2100_2114del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333828.1" sequenceAccession="NP_001333828" sequenceVersion="1" change="p.Glu701_Ala705del">
            <Expression>NP_001333828.1:p.Glu701_Ala705del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346900.2" sequenceAccession="NM_001346900" sequenceVersion="2" change="c.2076_2090del">
            <Expression>NM_001346900.2:c.2076_2090del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333829.1" sequenceAccession="NP_001333829" sequenceVersion="1" change="p.Glu693_Ala697del">
            <Expression>NP_001333829.1:p.Glu693_Ala697del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346941.2" sequenceAccession="NM_001346941" sequenceVersion="2" change="c.1434_1448del">
            <Expression>NM_001346941.2:c.1434_1448del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333870.1" sequenceAccession="NP_001333870" sequenceVersion="1" change="p.Glu479_Ala483del">
            <Expression>NP_001333870.1:p.Glu479_Ala483del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005228.5" sequenceAccession="NM_005228" sequenceVersion="5" change="c.2235_2249del" MANESelect="true">
            <Expression>NM_005228.5:c.2235_2249del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005219.2" sequenceAccession="NP_005219" sequenceVersion="2" change="p.Glu746_Ala750del">
            <Expression>NP_005219.2:p.Glu746_Ala750del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_304" sequenceAccession="LRG_304">
            <Expression>LRG_304:g.160741_160755del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA175996" DB="ClinGen" />
        <XRef Type="rs" ID="121913421" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005228.5(EGFR):c.2235_2249del (p.Glu746_Ala750del) AND Tyrosine kinase inhibitor response" Accession="RCV000150617" Version="4">
        <ClassifiedConditionList TraitSetID="20542">
          <ClassifiedCondition DB="MedGen" ID="CN225347">Tyrosine kinase inhibitor response</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-10-28" SubmissionCount="1">drug response</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005228.5(EGFR):c.2235_2249del (p.Glu746_Ala750del) AND EGFR-related lung cancer" Accession="RCV002514895" Version="2">
        <ClassifiedConditionList TraitSetID="9187">
          <ClassifiedCondition DB="MedGen" ID="CN130014">EGFR-related lung cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-27" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005228.5(EGFR):c.2235_2249del (p.Glu746_Ala750del) AND Lung adenocarcinoma" Accession="RCV003128584" Version="3">
        <ClassifiedConditionList TraitSetID="3349">
          <ClassifiedCondition DB="MedGen" ID="C0152013">Lung adenocarcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-27" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-01-31" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">15118073</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15118125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26066407</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29228562</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-03-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic; drug response</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-12-10">
          <Description>drug response</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20542" Type="DrugResponse" ContributesToAggregateClassification="false">
            <Trait ID="32633" Type="DrugResponse">
              <Name>
                <ElementValue Type="Alternate">Protein-tyrosine kinase inhibitor response</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosine kinase inhibitor response</ElementValue>
              </Name>
              <XRef ID="CN225347" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9187" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16754" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">EGFR-related lung cancer</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EGFR</ElementValue>
              </Symbol>
              <Citation Type="general" Abbrev="ACCP, 2013">
                <ID Source="PubMed">23649446</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAP/IASLC/AMP, 2013">
                <ID Source="PubMed">23562183</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Pasche et al., 2014">
                <ID Source="PubMed">24846033</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="Westwood et al., 2014">
                <ID Source="PubMed">24827857</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/CAP/IASLC/AMP, 2014">
                <ID Source="PubMed">25311215</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCPSG, 2013">
                <ID Source="PubMed">23667368</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/CAP/IASLC/AMP, 2018">
                <ID Source="PubMed">29355391</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCPSG, 2019">
                <ID Source="PubMed">30813707</ID>
              </Citation>
              <XRef ID="CN130014" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3349" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6499" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Adenocarcinoma of lung</ElementValue>
                <XRef ID="Adenocarcinoma+of+Lung/222" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lung adenocarcinoma</ElementValue>
                <XRef ID="HP:0030078" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005061" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenocarcinoma of lung, somatic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5742" />
                <XRef ID="5742" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CAP/IASLC/AMP, 2013">
                <ID Source="PubMed">23562183</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/CAP/IASLC/AMP, 2014">
                <ID Source="PubMed">25311215</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCPSG, 2014">
                <ID Source="PubMed">24627688</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/CAP/IASLC/AMP, 2018">
                <ID Source="PubMed">29355391</ID>
              </Citation>
              <Citation Type="general" Abbrev="CAP/IASLC/AMP, 2018">
                <ID Source="PubMed">29398453</ID>
              </Citation>
              <XRef ID="C0152013" DB="MedGen" />
              <XRef ID="D000077192" DB="MeSH" />
              <XRef ID="MONDO:0005061" DB="MONDO" />
              <XRef Type="primary" ID="HP:0030078" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5918313" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17322222|MedGen:CN130014" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003225329" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26066407</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29228562</ID>
          </Citation>
          <Comment>While this variant has not been reported in the germline of individuals with EGFR-related disease, it is a commonly reported somatic change in lung cancer (PMID: 26066407, 29228562). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 163343). This variant is not present in population databases (gnomAD no frequency). This variant, c.2235_2249del, results in the deletion of 5 amino acid(s) of the EGFR protein (p.Glu746_Ala750del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EGFR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.55242465_55242479del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN130014" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="355860" SubmissionDate="2015-01-26" DateLastUpdated="2015-01-31" DateCreated="2015-01-31">
        <ClinVarSubmissionID localKey="2991264|Tyrosine kinase inhibitor response" />
        <ClinVarAccession Accession="SCV000197913" DateUpdated="2015-01-31" DateCreated="2015-01-31" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-10-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>drug response</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15118125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15118073</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="136" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="149" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EGFR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="-" referenceAllele="GGAATTAAGAGAAGC" start="55242465" stop="55242479" variantLength="15" />
            <GeneLocation>NM_005228.3:EXON 19</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_005228.3:c.2235_2249del</Name>
            <Name>p.Glu746_Ala750del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.55242465_55242479del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="DrugResponse">
          <Trait Type="DrugResponse">
            <Name>
              <ElementValue Type="Preferred">Tyrosine kinase inhibitor response</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>LMM_all.variants_NCBI_3.16.2013</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7111565" SubmissionDate="2023-02-20" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="dk" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003806296" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Liquid Biopsy and Cancer Interception Group, Pfizer-University of Granada-Junta de AndalucÃ­a Centre for Genomics and Oncological Research" OrgID="507109" OrganizationCategory="laboratory" OrgAbbreviation="LB&amp;CI (L5)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">AMP Guidelines, 2017</Attribute>
          <Citation>
            <ID Source="PubMed">27993330</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">PCT46</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EGFR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005228.5:c.2235_2249del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0005061" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12873739</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7566303" SubmissionDate="2023-10-17" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey=":Chr.7_55242465_55242479_GGAATTAAGAGAAGC_-|Adenocarcinoma of lung" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004042727" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Key Laboratory of Carcinogenesis and Cancer Invasion, Central South University" OrgID="509306" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EGFR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="-" referenceAllele="GGAATTAAGAGAAGC" start="55242465" stop="55242479" variantLength="15" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Adenocarcinoma of lung</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13905799</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="355860" TraitType="DrugResponse" MappingType="Name" MappingValue="Tyrosine kinase inhibitor response" MappingRef="Preferred">
        <MedGen CUI="CN225347" Name="Tyrosine kinase inhibitor response" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7111565" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0005061" MappingRef="MONDO">
        <MedGen CUI="C0152013" Name="Lung adenocarcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7566303" TraitType="Disease" MappingType="Name" MappingValue="Adenocarcinoma of lung" MappingRef="Preferred">
        <MedGen CUI="C0152013" Name="Lung adenocarcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5918313" TraitType="Disease" MappingType="XRef" MappingValue="CN130014" MappingRef="MedGen">
        <MedGen CUI="CN130014" Name="EGFR-related lung cancer" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-10-11">SCV002759818</Accession>
        <Description>Variant to be re-evaluated and re-classified.</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

